2021
DOI: 10.1071/ma21034
|View full text |Cite
|
Sign up to set email alerts
|

‘The awesome power of yeast’ in Alzheimer’s disease research

Abstract: The difficulties in performing experimental studies related to diseases of the human brain have fostered a range of disease models from highly expensive and complex animal models to simple, robust, unicellular yeast models. Yeast models have been used in numerous studies to understand Alzheimer's disease (AD) pathogenesis and to search for drugs targeting AD. Thanks to the conservation of fundamental eukaryotic processes including ageing and the availability of appropriate technological platforms, budding yeas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 27 publications
(41 reference statements)
0
4
0
Order By: Relevance
“…As mentioned previously, yeast cells and human cells share certain biological characteristics. For example, yeast has considerable utility as a model for aging [ 63 ]. Aging yeast and aging human cells show reduced proteostasis, which means that some deleterious proteins accumulate with age.…”
Section: Simvastatin Reduces the Incidence Of Alzheimer’s Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…As mentioned previously, yeast cells and human cells share certain biological characteristics. For example, yeast has considerable utility as a model for aging [ 63 ]. Aging yeast and aging human cells show reduced proteostasis, which means that some deleterious proteins accumulate with age.…”
Section: Simvastatin Reduces the Incidence Of Alzheimer’s Diseasementioning
confidence: 99%
“…In addition, amyloid beta can be visualized by fusing it to fluorescent proteins such as GFP, where it can be observed in cells by fluorescence microscopy [ 65 ]. Examinations of cell populations show that young cells remove amyloid beta fused to GFP, while in older (larger) cells, the amyloid beta fused to GFP persists [ 63 ]. When the yeast is grown in the presence of simvastatin, the levels of amyloid beta or amyloid beta fused to GFP are about 10% of those in untreated cells [ 41 ].…”
Section: Simvastatin Reduces the Incidence Of Alzheimer’s Diseasementioning
confidence: 99%
“…Reporter systems in yeast biosensors can be based on fluorescence, luminescence, enzymatic reactions (usually measured with a color change in substrates), electrical signal, and growth rate [44]. Interestingly, yeast biosensors can be used to study the status of mitochondrial health, which is unique to yeast and cannot be performed in any other system [48]. Hence, yeast can be used as a biosensor to find chemicals that can modify mitochondrial health.…”
Section: Yeast Reportersmentioning
confidence: 99%
“…Aβ probably has a somewhat non-specific effect on cells, with the deleterious effects being due to its accumulation. By studying yeast with GFP fused to Aβ we observed that in the population, despite all cells producing the fusion protein, young cells remove the fusion protein, so no young cells are fluorescent [48]; however, old cells retained the protein and had green fluorescence. This phenomenon is likely to be due to reduced proteostasis, a phenomenon that is also a significant part of human aging.…”
Section: Fluorescent Biosensors For Studying Neurodegenerative Diseasesmentioning
confidence: 99%